BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19117119)

  • 1. Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.
    He S; Zhang D; Cheng F; Gong F; Guo Y
    Mol Biol Rep; 2009 Nov; 36(8):2153-63. PubMed ID: 19117119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi in clinical studies.
    Kubowicz P; Żelaszczyk D; Pękala E
    Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference and cancer therapy.
    Wang Z; Rao DD; Senzer N; Nemunaitis J
    Pharm Res; 2011 Dec; 28(12):2983-95. PubMed ID: 22009588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dicey role of Dicer: implications for RNAi therapy.
    Merritt WM; Bar-Eli M; Sood AK
    Cancer Res; 2010 Apr; 70(7):2571-4. PubMed ID: 20179193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on RNA interference-mediated gene silencing in cancer therapy.
    Ren YJ; Zhang Y
    Expert Opin Biol Ther; 2014 Nov; 14(11):1581-92. PubMed ID: 25010067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concepts in in vivo siRNA delivery for cancer therapy.
    Gondi CS; Rao JS
    J Cell Physiol; 2009 Aug; 220(2):285-91. PubMed ID: 19391103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy.
    Cheng F; He S
    Mol Biol Rep; 2010 Jul; 37(6):2635-44. PubMed ID: 19757182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi: gene-silencing in therapeutic intervention.
    Shuey DJ; McCallus DE; Giordano T
    Drug Discov Today; 2002 Oct; 7(20):1040-6. PubMed ID: 12546893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances, nuances, and potential pitfalls when exploiting the therapeutic potential of RNA interference.
    Battistella M; Marsden PA
    Clin Pharmacol Ther; 2015 Jan; 97(1):79-87. PubMed ID: 25670385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illuminating the gateway of gene silencing: perspective of RNA interference technology in clinical therapeutics.
    Sindhu A; Arora P; Chaudhury A
    Mol Biotechnol; 2012 Jul; 51(3):289-302. PubMed ID: 21947958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA as a route to new cancer therapies.
    Ameyar-Zazoua M; Guasconi V; Ait-Si-Ali S
    Expert Opin Biol Ther; 2005 Feb; 5(2):221-4. PubMed ID: 15757383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference: a potent tool for gene-specific therapeutics.
    Ichim TE; Li M; Qian H; Popov IA; Rycerz K; Zheng X; White D; Zhong R; Min WP
    Am J Transplant; 2004 Aug; 4(8):1227-36. PubMed ID: 15268723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vivo siRNA delivery to tumor cells and its application to cancer gene therapy].
    Takahashi Y; Nishikawa M; Takakura Y
    Yakugaku Zasshi; 2007 Oct; 127(10):1525-31. PubMed ID: 17917414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combinatorial RNAi and its application in cancer gene therapy].
    Fei LN; Wang QZ; Xu RA
    Yao Xue Xue Bao; 2012 May; 47(5):573-9. PubMed ID: 22811998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interfering with disease: opportunities and roadblocks to harnessing RNA interference.
    Lieberman J; Song E; Lee SK; Shankar P
    Trends Mol Med; 2003 Sep; 9(9):397-403. PubMed ID: 13129706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
    Hong CA; Nam YS
    Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
    Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
    Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy.
    Chen Y; Huang L
    Expert Opin Drug Deliv; 2008 Dec; 5(12):1301-11. PubMed ID: 19040393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.